PHVS
Pharvaris BV
31.20$
+0.6%
vs. previous close
Closing price · As of: Oct 2, 2026
Statements
Balance Sheet
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|
| – | +13.3% | +279.0% | +390.8% | +109.8% | -20.9% | +137.7% | -26.9% | +3.5% | |
| – | +13.3% | +278.8% | +390.4% | +109.6% | -21.1% | +138.5% | -27.3% | +3.4% | |
| – | +12.3% | +277.4% | +385.2% | +112.3% | -22.7% | +141.7% | -28.2% | +3.9% | |
| – | +12.3% | +277.4% | +385.2% | +112.3% | -22.7% | +141.7% | -28.2% | +3.9% | |
| – | +2,402.2% | +698.0% | +170.1% | +22.9% | -45.4% | +171.7% | +183.4% | +54.6% | |
| – | – | – | – | +178.9% | +168.2% | -108.0% | – | – | |
| – | – | – | +275.2% | +624.4% | +78.3% | – | – | – | |
| – | +246.7% | +299.7% | +176.2% | +34.3% | +158.8% | -20.7% | +61.2% | +27.8% | |
| – | +246.7% | +299.7% | +176.2% | +31.5% | +160.9% | -19.9% | +57.3% | +28.9% | |
| – | – | – | – | – | +88.5% | +4.2% | +13.9% | -10.0% | |
| – | +307.4% | +110.2% | +26.8% | +223.8% | +181.3% | -51.3% | +56.8% | +12.1% | |
| – | +6.3% | +277.0% | +412.9% | +114.0% | -27.2% | +157.3% | -30.3% | +1.3% | |
| – | – | – | – | – | – | – | – | – | |
| – | +4.3% | +0.0% | -4.1% | -0.4% | +10.4% | +14.3% | +40.7% | +9.5% |
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.